hPSCreg is a freely accessible global registry for human pluripotent stem cell lines (hPSC-lines), which is managed by Charité / BCRT . The registry allows searching for cell lines and for information available about these cell lines. New cell lines can be registered and information can be added to already registered cell lines.
hPSCreg is an open platform for coordination and cooperation in the area of hPSC research and application, to avoid redundancy and ensuring comparable quality standards in hPSC research. hPSCreg aims to collaborate with registries and cell banks worldwide.
hPSCreg was established in 2007 as the European human embryonic stem cell registry and is supported by the European Commission.
Why register cell lines?
Registration of a cell line in hPSCreg confirms ethical procurement and scientific evidence for pluripotency to the global community. The registry collects, validates, and stores additional information related to the pluripotent cell lines. Registration of cell lines in hPSCreg will provide visibility, confidence in ethical provenance, validation of characterization data, and comparability with other registered lines. Any scientist or institution generating or working with PSC lines can register their cell lines.
What is registered?
hPSCreg provides comprehensive information on existing hPSC lines, their ethical procurement, derivation process, genetic and expression data and other molecular or biological characteristics, use, and quality of the line. The information on each line can be updated, edited and completed. The hPSCreg database is a dynamic database, in that the content of the database is updated through regular surveys conducted by the Steering Committee and feedback from hPSC-line providers. All information collated undergoes a standardized validation process.
Should you experience any problems operating the database or would like to contribute to its further development please contact us.
- Guhr A et al. Recent Trends in Research with Human Pluripotent Stem Cells: Impact of Research and Use of Cell Lines in Experimental Research and Clinical Trials. Stem cell reports. 2018 Aug 14;11(2):485-496.
- Kurtz A et al. A Standard Nomenclature for Referencing and Authentication of Pluripotent Stem Cells. Stem cell reports. 2018 Jan 9;10(1):1-6.
- Kim JH et al. Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells. Stem cells translational medicine. 2017 Nov;6(11):1956-1962.
- De Sousa PA et al. Rapid establishment of the European Bank for induced Pluripotent Stem Cells (EBiSC) - the Hot Start experience. Stem cell research. 2017 Apr;20:105-114.
- Seltmann S et al. hPSCreg--the human pluripotent stem cell registry. Nucleic acids research. 2016 Jan 4;44(D1):D757-63.
- Sermon KD et al. Creation of a registry for human embryonic stem cells carrying an inherited defect: joint collaboration between ESHRE and hESCreg. Human reproduction (Oxford, England). 2009 Jul;24(7):1556-60.
- Elstner A et al. The changing landscape of European and international regulation on embryonic stem cell research. Stem cell research. 2009 Mar;2(2):101-7.
- Borstlap J et al. Development of a European human embryonic stem cell registry. Regenerative medicine. 2008 Nov;3(6):945-51.
- Borstlap J et al. First evaluation of the European hESCreg. Nature biotechnology. 2008 Aug;26(8):859-60.